Eosinophilic xanthomatous granulomatosis and Letterer-Siwe's disease.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D001842:Bone and Bones / Q000000981:diagnostic imaging; D002675:Child, Preschool; D003348:Cortisone / Q000627:therapeutic use; D004803:Eosinophilic Granuloma / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D004804:Eosinophils / Q000254:growth & development; D005260:Female; D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy / Q000473:pathology / Q000628:therapy; D006801:Humans; D007223:Infant; D007958:Leukocyte Count; D008168:Lung / Q000000981:diagnostic imaging; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D009912:Oral Manifestations; D011859:Radiography; D012867:Skin / Q000473:pathology; D012877:Skin Manifestations; D012886:Skull / Q000000981:diagnostic imaging
D000970:Antineoplastic Agents; D000324:Adrenocorticotropic Hormone; D003348:Cortisone